<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://peir.path.uab.edu/index.php?action=history&amp;feed=atom&amp;title=Cytologically_Yours%3A_Unknowns%3A_201310%3A_Case_1</id>
	<title>Cytologically Yours: Unknowns: 201310: Case 1 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://peir.path.uab.edu/index.php?action=history&amp;feed=atom&amp;title=Cytologically_Yours%3A_Unknowns%3A_201310%3A_Case_1"/>
	<link rel="alternate" type="text/html" href="https://peir.path.uab.edu/index.php?title=Cytologically_Yours:_Unknowns:_201310:_Case_1&amp;action=history"/>
	<updated>2026-04-12T10:47:32Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.31.1</generator>
	<entry>
		<id>https://peir.path.uab.edu/index.php?title=Cytologically_Yours:_Unknowns:_201310:_Case_1&amp;diff=2268&amp;oldid=prev</id>
		<title>Seung Park: 1 revision</title>
		<link rel="alternate" type="text/html" href="https://peir.path.uab.edu/index.php?title=Cytologically_Yours:_Unknowns:_201310:_Case_1&amp;diff=2268&amp;oldid=prev"/>
		<updated>2014-01-09T19:29:24Z</updated>

		<summary type="html">&lt;p&gt;1 revision&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 19:29, 9 January 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Seung Park</name></author>
		
	</entry>
	<entry>
		<id>https://peir.path.uab.edu/index.php?title=Cytologically_Yours:_Unknowns:_201310:_Case_1&amp;diff=2267&amp;oldid=prev</id>
		<title>SeungPark at 22:28, 13 November 2013</title>
		<link rel="alternate" type="text/html" href="https://peir.path.uab.edu/index.php?title=Cytologically_Yours:_Unknowns:_201310:_Case_1&amp;diff=2267&amp;oldid=prev"/>
		<updated>2013-11-13T22:28:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Clinical History==&lt;br /&gt;
55 year old male with a right upper lobe lung mass and mediastinal adenopathy.&lt;br /&gt;
The patient is a smoker.&lt;br /&gt;
&lt;br /&gt;
==Cytology==&lt;br /&gt;
&amp;lt;gallery heights=&amp;quot;250px&amp;quot; widths=&amp;quot;250px&amp;quot;&amp;gt;&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-01.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-02.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-03.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-04.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-05.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-06.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-07.jpg&lt;br /&gt;
CytologicallyYoursUnknowns201310-1-08.jpg&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Resident Questions===&lt;br /&gt;
* &amp;lt;spoiler text=&amp;quot;Diagnosis?&amp;quot;&amp;gt;Adenocarcinoma. &amp;lt;/spoiler&amp;gt;&lt;br /&gt;
* &amp;lt;spoiler text=&amp;quot;What genetic mutations, if any, are associated with this diagnosis?&amp;quot;&amp;gt;&lt;br /&gt;
* EGFR testing is performed on these tumors to select patients for tyrosine kinase inhibitor (TKI)therapy (Gefitinib).&lt;br /&gt;
* Patients with EML4-ALK fusion, respond to ALK inhibitor (ALKI) (Crizotinib)&lt;br /&gt;
** Deletion and inversion on Chromosome 2p&lt;br /&gt;
* Patients with KRAS or BRAF mutation do not respond to TKI, ALKI&lt;br /&gt;
* KRAS mutations tend to be an adverse prognostic sign&lt;br /&gt;
** Seen in mucinous type tumors, smokers and those of non-Asian ancestry&lt;br /&gt;
** Most common mutations are in codons 12 and 13 of exon 2&lt;br /&gt;
* EGFR&lt;br /&gt;
** Point mutation or substitution mutation in the EGFR tyrosine kinase domain&lt;br /&gt;
*** Sensitive to EGFR tyrosine kinase inhibitors&lt;br /&gt;
**** Exons 19 deletion&lt;br /&gt;
**** Exon 21 L858R&lt;br /&gt;
**** Exon 18 G719&lt;br /&gt;
*** Resistance to EGFR tyrosine kinase inhibitors&lt;br /&gt;
**** Exon 20 (insertion V769L, S768I)&lt;br /&gt;
**** Exon 19 (D761Y)&lt;br /&gt;
&amp;lt;/spoiler&amp;gt;&lt;br /&gt;
* &amp;lt;spoiler text=&amp;quot;Why is it important to distinguish between adenocarcinoma and squamous cell carcinoma?&amp;quot;&amp;gt;  &lt;br /&gt;
* Treatment&lt;br /&gt;
** EGFR mutations are found in adenocarcinoma and in some adenosquamous carcinomas&lt;br /&gt;
** Bevacizumab is a monoclonal antibody that blocks vascular endothelial growth factor A (VEGF-A), which stimulates angiogenesis in cancer&lt;br /&gt;
** Association between fatal hemoptysis in patients with squamous cell carcinoma of the lung treated with Bevacizumab&lt;br /&gt;
*** Therefore, Bevacizumab is contraindicated for tumors with squamous cell histology&lt;br /&gt;
&amp;lt;/spoiler&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Additional Teaching Points==&lt;br /&gt;
===Immunohistochemistry===&lt;br /&gt;
* TTF-1 (nuclear stain)&lt;br /&gt;
** Thyroid Transcription factor1 regulates transcription of genes specific to the thyroid, lung, and diencephalon&lt;br /&gt;
** If metastatic thyroid cancer to the lung is ruled out by morphology or +thyroglobulin; then a +TTF1 supports adenocarcinoma originating from the lung&lt;br /&gt;
* P63 (nuclear stain) and 34BE12 (cytoplasmic stain)&lt;br /&gt;
** Used for squamous differentiation&lt;br /&gt;
* TTF1 is more sensitive than p63&lt;br /&gt;
** If a tumor stains for both it is more likely to be adenocarcinoma&lt;br /&gt;
* Napsin A(cytoplasmic stain)&lt;br /&gt;
** Granular staining pattern&lt;br /&gt;
** Marker for adenocarcinoma&lt;br /&gt;
&lt;br /&gt;
{{Cytologically Yours}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Unknowns]]&lt;br /&gt;
[[Category:Respiratory]]&lt;/div&gt;</summary>
		<author><name>SeungPark</name></author>
		
	</entry>
</feed>